Original source (on modern site) | Article images: [1] [2]
Matej Kastelic/Shutterstock
Cresset's Dr Rob Scoffin outlines the power of AI to accelerate drug discovery and reduce the chance for late-stage drug candidate failures
Welcome to Scientific Computing World Already registered? Sign in to continue reading Not got an account? Register for free to continue reading
With 63rd edition of the TOP500 has Frontier remained in its top spot now that it has been joined by a second exascale supercomputer?
Overcoming key challenges in drug discovery and development: ADMET prediction with AI techniques
Editor's picks
Has Frontier lost the exascale top spot?
![[1]](image.php?loc=EG&i=/sites/default/files/styles/content_banner/public/2024-05/Matej%20Kastelic%20shutterstock_639884194.jpg?h=c6980913&itok=Mb5N94oE){kind=link}
![[2]](image.php?loc=EG&i=/sites/default/files/styles/jumbotron/public/2024-05/Frontier.jpg?h=c71d0c67&itok=IZJefvTP){kind=link}